Superinhibitory Phospholemman Mutants as Potential Therapeutics for Heart Failure

Biophysical Journal - United States
doi 10.1016/j.bpj.2012.11.868
Full Text
Abstract

Available in full text

Categories
Biophysics
Date
Authors
Publisher

Elsevier BV

Related search

PPAR Agonists: Potential as Therapeutics for Neovascular Retinopathies

PPAR Research
Drug DiscoveryPharmacology
2008English

Extracellular Vesicles as Novel Therapeutics in Hepatic Failure

Hepatology
MedicineHepatology
2018English

Heat Shock Protein 70 Acts as a Potential Biomarker for Early Diagnosis of Heart Failure

PLoS ONE
Multidisciplinary
2013English

Anti-Transcription Factor RNA Aptamers as Potential Therapeutics

Nucleic Acid Therapeutics
BiochemistryMolecular MedicineDrug DiscoveryGeneticsMolecular Biology
2016English

Targeting Myocardial Substrate Metabolism in Heart Failure: Potential for New Therapies

European Journal of Heart Failure
Cardiovascular MedicineCardiology
2012English

Inhibitors of Connexin and Pannexin Channels as Potential Therapeutics

Pharmacology and Therapeutics
Pharmacology
2017English

MicroRNA 210 as a Biomarker for Congestive Heart Failure

Biological and Pharmaceutical Bulletin
MedicinePharmacologyPharmaceutical Science
2013English

Nitroxyl, Redox Switches, Cardiac Myofilaments, and Heart Failure: A Prequel to Novel Therapeutics?

Circulation Research
Cardiovascular MedicinePhysiologyCardiology
2012English

Potential Drug-Drug Interactions in Heart Failure Patients

International Journal of Pharmacy and Pharmaceutical Sciences
PharmacologyPharmaceutical Science
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy